Selected research
Market Analysis & Forecast
Global Pharma-Grade Hyaluronic Acid Market Analysis and Forecast 2026-2032
Market perspective
The global Pharma-Grade Hyaluronic Acid market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pharma-Grade Hyaluronic Acid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pharma-Grade Hyaluronic Acid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pharma-Grade Hyaluronic Acid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pharma-Grade Hyaluronic Acid is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Pharma-Grade Hyaluronic Acid include Bloomage BioTechnology, AWA Biopharm, Kewpie, Contipro, Seikagaku, HTL Biotechnology and Fidia Farmaceutici, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pharma-Grade Hyaluronic Acid, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pharma-Grade Hyaluronic Acid, also provides the sales of main regions and countries. Of the upcoming market potential for Pharma-Grade Hyaluronic Acid, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharma-Grade Hyaluronic Acid sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharma-Grade Hyaluronic Acid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pharma-Grade Hyaluronic Acid sales, projected growth trends, production technology, application and end-user industry.
Pharma-Grade Hyaluronic Acid Segment by Company
Bloomage BioTechnology
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Pharma-Grade Hyaluronic Acid Segment by Type
Injection Grade Hyaluronic Acid
Eye Drops Grade Hyaluronic Acid
Pharma-Grade Hyaluronic Acid Segment by Application
Auxiliary Agents for Eye Surgery
Therapeutic Agents
Pharma-Grade Hyaluronic Acid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma-Grade Hyaluronic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma-Grade Hyaluronic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma-Grade Hyaluronic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pharma-Grade Hyaluronic Acid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pharma-Grade Hyaluronic Acid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma-Grade Hyaluronic Acid sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Grade Hyaluronic Acid
- Eye Drops Grade Hyaluronic Acid
Applications
- Auxiliary Agents for Eye Surgery
- Therapeutic Agents
Companies covered
- Bloomage BioTechnology
- AWA Biopharm
- Kewpie
- Contipro
- Seikagaku
- HTL Biotechnology
- Fidia Farmaceutici
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pharma-Grade Hyaluronic Acid Market by Type
- 1.2.1 Global Pharma-Grade Hyaluronic Acid Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Injection Grade Hyaluronic Acid
- 1.2.3 Eye Drops Grade Hyaluronic Acid
- 1.3 Pharma-Grade Hyaluronic Acid Market by Application
- 1.3.1 Global Pharma-Grade Hyaluronic Acid Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Auxiliary Agents for Eye Surgery
- 1.3.3 Therapeutic Agents
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharma-Grade Hyaluronic Acid Market Dynamics
- 2.1 Pharma-Grade Hyaluronic Acid Industry Trends
- 2.2 Pharma-Grade Hyaluronic Acid Industry Drivers
- 2.3 Pharma-Grade Hyaluronic Acid Industry Opportunities and Challenges
- 2.4 Pharma-Grade Hyaluronic Acid Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Pharma-Grade Hyaluronic Acid Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Region
- 3.2.1 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pharma-Grade Hyaluronic Acid Revenue by Region (2021-2026)
- 3.2.3 Global Pharma-Grade Hyaluronic Acid Revenue by Region (2027-2032)
- 3.2.4 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Region (2021-2032)
- 3.3 Global Pharma-Grade Hyaluronic Acid Sales Estimates and Forecasts 2021-2032
- 3.4 Global Pharma-Grade Hyaluronic Acid Sales by Region
- 3.4.1 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Pharma-Grade Hyaluronic Acid Sales by Region (2021-2026)
- 3.4.3 Global Pharma-Grade Hyaluronic Acid Sales by Region (2027-2032)
- 3.4.4 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturers
- 4.1.1 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Pharma-Grade Hyaluronic Acid Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pharma-Grade Hyaluronic Acid Sales by Manufacturers
- 4.2.1 Global Pharma-Grade Hyaluronic Acid Sales by Manufacturers (2021-2026)
- 4.2.2 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Pharma-Grade Hyaluronic Acid Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Pharma-Grade Hyaluronic Acid Sales Price by Manufacturers (2021-2026)
- 4.4 Global Pharma-Grade Hyaluronic Acid Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Pharma-Grade Hyaluronic Acid Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Pharma-Grade Hyaluronic Acid Manufacturers, Product Type & Application
- 4.7 Global Pharma-Grade Hyaluronic Acid Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Pharma-Grade Hyaluronic Acid Market CR5 and HHI
- 4.8.2 2025 Pharma-Grade Hyaluronic Acid Tier 1, Tier 2, and Tier 3
5 Pharma-Grade Hyaluronic Acid Market by Type
- 5.1 Global Pharma-Grade Hyaluronic Acid Revenue by Type
- 5.1.1 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2021-2032)
- 5.2 Global Pharma-Grade Hyaluronic Acid Sales by Type
- 5.2.1 Global Pharma-Grade Hyaluronic Acid Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032) & (Kg)
- 5.2.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2021-2032)
- 5.3 Global Pharma-Grade Hyaluronic Acid Price by Type
6 Pharma-Grade Hyaluronic Acid Market by Application
- 6.1 Global Pharma-Grade Hyaluronic Acid Revenue by Application
- 6.1.1 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2021-2032)
- 6.2 Global Pharma-Grade Hyaluronic Acid Sales by Application
- 6.2.1 Global Pharma-Grade Hyaluronic Acid Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032) & (Kg)
- 6.2.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2021-2032)
- 6.3 Global Pharma-Grade Hyaluronic Acid Price by Application
7 Company Profiles
- 7.1 Bloomage BioTechnology
- 7.1.1 Bloomage BioTechnology Company Information
- 7.1.2 Bloomage BioTechnology Business Overview
- 7.1.3 Bloomage BioTechnology Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Bloomage BioTechnology Pharma-Grade Hyaluronic Acid Product Portfolio
- 7.1.5 Bloomage BioTechnology Recent Developments
- 7.2 AWA Biopharm
- 7.2.1 AWA Biopharm Company Information
- 7.2.2 AWA Biopharm Business Overview
- 7.2.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Product Portfolio
- 7.2.5 AWA Biopharm Recent Developments
- 7.3 Kewpie
- 7.3.1 Kewpie Company Information
- 7.3.2 Kewpie Business Overview
- 7.3.3 Kewpie Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Kewpie Pharma-Grade Hyaluronic Acid Product Portfolio
- 7.3.5 Kewpie Recent Developments
- 7.4 Contipro
- 7.4.1 Contipro Company Information
- 7.4.2 Contipro Business Overview
- 7.4.3 Contipro Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Contipro Pharma-Grade Hyaluronic Acid Product Portfolio
- 7.4.5 Contipro Recent Developments
- 7.5 Seikagaku
- 7.5.1 Seikagaku Company Information
- 7.5.2 Seikagaku Business Overview
- 7.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Product Portfolio
- 7.5.5 Seikagaku Recent Developments
- 7.6 HTL Biotechnology
- 7.6.1 HTL Biotechnology Company Information
- 7.6.2 HTL Biotechnology Business Overview
- 7.6.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product Portfolio
- 7.6.5 HTL Biotechnology Recent Developments
- 7.7 Fidia Farmaceutici
- 7.7.1 Fidia Farmaceutici Company Information
- 7.7.2 Fidia Farmaceutici Business Overview
- 7.7.3 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product Portfolio
- 7.7.5 Fidia Farmaceutici Recent Developments
8 North America
- 8.1 North America Pharma-Grade Hyaluronic Acid Market Size by Type
- 8.1.1 North America Pharma-Grade Hyaluronic Acid Revenue by Type (2021-2032)
- 8.1.2 North America Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032)
- 8.1.3 North America Pharma-Grade Hyaluronic Acid Price by Type (2021-2032)
- 8.2 North America Pharma-Grade Hyaluronic Acid Market Size by Application
- 8.2.1 North America Pharma-Grade Hyaluronic Acid Revenue by Application (2021-2032)
- 8.2.2 North America Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032)
- 8.2.3 North America Pharma-Grade Hyaluronic Acid Price by Application (2021-2032)
- 8.3 North America Pharma-Grade Hyaluronic Acid Market Size by Country
- 8.3.1 North America Pharma-Grade Hyaluronic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Pharma-Grade Hyaluronic Acid Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Pharma-Grade Hyaluronic Acid Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Pharma-Grade Hyaluronic Acid Market Size by Type
- 9.1.1 Europe Pharma-Grade Hyaluronic Acid Revenue by Type (2021-2032)
- 9.1.2 Europe Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032)
- 9.1.3 Europe Pharma-Grade Hyaluronic Acid Price by Type (2021-2032)
- 9.2 Europe Pharma-Grade Hyaluronic Acid Market Size by Application
- 9.2.1 Europe Pharma-Grade Hyaluronic Acid Revenue by Application (2021-2032)
- 9.2.2 Europe Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032)
- 9.2.3 Europe Pharma-Grade Hyaluronic Acid Price by Application (2021-2032)
- 9.3 Europe Pharma-Grade Hyaluronic Acid Market Size by Country
- 9.3.1 Europe Pharma-Grade Hyaluronic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Pharma-Grade Hyaluronic Acid Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Pharma-Grade Hyaluronic Acid Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Pharma-Grade Hyaluronic Acid Market Size by Type
- 10.1.1 China Pharma-Grade Hyaluronic Acid Revenue by Type (2021-2032)
- 10.1.2 China Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032)
- 10.1.3 China Pharma-Grade Hyaluronic Acid Price by Type (2021-2032)
- 10.2 China Pharma-Grade Hyaluronic Acid Market Size by Application
- 10.2.1 China Pharma-Grade Hyaluronic Acid Revenue by Application (2021-2032)
- 10.2.2 China Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032)
- 10.2.3 China Pharma-Grade Hyaluronic Acid Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pharma-Grade Hyaluronic Acid Market Size by Type
- 11.1.1 Asia Pharma-Grade Hyaluronic Acid Revenue by Type (2021-2032)
- 11.1.2 Asia Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032)
- 11.1.3 Asia Pharma-Grade Hyaluronic Acid Price by Type (2021-2032)
- 11.2 Asia Pharma-Grade Hyaluronic Acid Market Size by Application
- 11.2.1 Asia Pharma-Grade Hyaluronic Acid Revenue by Application (2021-2032)
- 11.2.2 Asia Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032)
- 11.2.3 Asia Pharma-Grade Hyaluronic Acid Price by Application (2021-2032)
- 11.3 Asia Pharma-Grade Hyaluronic Acid Market Size by Country
- 11.3.1 Asia Pharma-Grade Hyaluronic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Pharma-Grade Hyaluronic Acid Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Pharma-Grade Hyaluronic Acid Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pharma-Grade Hyaluronic Acid Market Size by Type
- 12.1.1 SAMEA Pharma-Grade Hyaluronic Acid Revenue by Type (2021-2032)
- 12.1.2 SAMEA Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032)
- 12.1.3 SAMEA Pharma-Grade Hyaluronic Acid Price by Type (2021-2032)
- 12.2 SAMEA Pharma-Grade Hyaluronic Acid Market Size by Application
- 12.2.1 SAMEA Pharma-Grade Hyaluronic Acid Revenue by Application (2021-2032)
- 12.2.2 SAMEA Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032)
- 12.2.3 SAMEA Pharma-Grade Hyaluronic Acid Price by Application (2021-2032)
- 12.3 SAMEA Pharma-Grade Hyaluronic Acid Market Size by Country
- 12.3.1 SAMEA Pharma-Grade Hyaluronic Acid Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Pharma-Grade Hyaluronic Acid Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Pharma-Grade Hyaluronic Acid Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Pharma-Grade Hyaluronic Acid Value Chain Analysis
- 13.1.1 Pharma-Grade Hyaluronic Acid Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Pharma-Grade Hyaluronic Acid Production Mode & Process
- 13.2 Pharma-Grade Hyaluronic Acid Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Pharma-Grade Hyaluronic Acid Distributors
- 13.2.3 Pharma-Grade Hyaluronic Acid Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst